CRIS is a consultancy and specialist services firm that provides assistance and support for the use of nuclear magnetic resonance imaging (MRI) and spectroscopy (MRS) as a non-invasive outcome measure in preclinical and clinical protocols, in particular therapeutic trials. Since its establishment 20 years ago, CRIS has provided its specialist expertise and research and analytical services to medical organisations and large pharmaceutical companies, helping trial sponsors in defining domains where NMR techniques can generate meaningful results, in setting up relevant acquisition sequences, and in collecting and analysing experimental data.
About CRIS
